Article Details
Retrieved on: 2018-03-19 21:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Medicxi has created an “ideas factory” to boost its capacity to turn early-stage science into pipelines of drug candidates and startups to develop them. The VC fund is setting up the venture with its CSO, David Grainger, Ph.D., and Johnson & Johnson's Richard Mason, M.D.. Anglo-Swiss investment group ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here